1-15 of 15
David Qualls
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Clinical use of genome-wide hi-c sequencing for assessment of structural variants in diffuse large B-cell lymphoma

Free
Phillip Michaels, David Qualls, Anthony Schmitt, Alex Hastie
Journal: Blood
Blood (2025) 146 (Supplement 1): 7862.
https://doi.org/10.1182/blood-2025-7862
Published: 2025
Journal Articles

Firicabtagene autoleucel (firi-cel), a CD22-directed CAR T-cell therapy, for patients with relapsed/refractory large B-cell lymphoma: Results from the phase 2 study (FIRCE-1 Trial)

Free
Matthew Frank, David Qualls, Armin Ghobadi, Jordan Gauthier, Michael Tees, Luke Mountjoy, Joseph McGuirk, Sattva Neelapu, Reem Karmali, Iris Isufi, Brian Hill, Craig Sauter, Catherine Diefenbach, Jay Spiegel, Lizamarie Bachier-Rodriguez, Monalisa Ghosh, Nirav Shah, Rahul Lakhotia, Francisco Hernandez-Ilizaliturri, Anuja Abhyankar, Elise Chong, Matthew Schwede, Krish Patel, Olalekan Oluwole, John Baird, Nathan Denlinger, Farrukh Awan, Michael Jain, John Timmerman, Cesar Sanchez, Muthu Kumaran, Jean Yared, Jon Arnason, Ishan Tatake, Usama Gergis, Peter Riedell, Keith Pratz, Nirali Shah
Journal: Blood
Blood (2025) 146 (Supplement 1): 667.
https://doi.org/10.1182/blood-2025-667
Published: 2025
Journal Articles

Phase I/II study of acalabrutinib, venetoclax, and obinutuzumab in patients with relapsed/refractory and previously untreated Mantle Cell Lymphoma (MAVO)

Free
Austin Kim, Peter Riedell, Christine Ryan, Robert Redd, Clare Phinney, Juniper Mai, Samantha Pazienza, Caitlin Bravo, Vanessa Kats, Salah Abdulkarim, Susan Waisgerber, Reid Merryman, David Fisher, Inhye Ahn, Jennifer Crombie, Oreofe Odejide, Ann LaCasce, Caron Jacobson, Eric Jacobsen, Erin Parry, David Qualls, Amy Bessnow, Matthew S Davids, Jennifer Brown, Jon Arnason, Michael Leukam, Philippe Armand, Justin Kline, Mark Murakami
Journal: Blood
Blood (2025) 146 (Supplement 1): 664.
https://doi.org/10.1182/blood-2025-664
Published: 2025
Journal Articles

Glofitamab and obinutuzumab (GLOBIN) as first-line therapy for patients with high-tumor burden follicular lymphoma: First results of a multicenter phase II trial

Free
Reid Merryman, Gottfried von Keudell, Robert Redd, Heather Walker, Jenna Mahns, Samantha Normilus, Siri Sagedahl, Ioulia Vogiatzi, Mingzeng Zhang, Emily Sumpena, Weihsin Chuan, Inhye Ahn, Amy Bessnow, Jennifer Brown, Jennifer Crombie, Matthew S Davids, David Fisher, Cynthia Hahn, Eric Jacobsen, Caron Jacobson, Austin Kim, Ann LaCasce, Oreofe Odejide, Erin Parry, David Qualls, Christine Ryan, Aswin Sekar, Hua-Jay Cherng, Mark Murakami, Philippe Armand, Joshua Brody
Journal: Blood
Blood (2025) 146 (Supplement 1): 3602.
https://doi.org/10.1182/blood-2025-3602
Published: 2025
Journal Articles

BMS-986458, a first-in-class, bifunctional cereblon-dependent ligand-directed degrader of B-cell lymphoma 6 (BCL6) in patients with Relapsed/Refractory (R/R) non-Hodgkin lymphoma (NHL): Updated results from the Phase 1 dose escalation study

Free
Franck Morschhauser, David Qualls, Jennifer Lue, Anastasios Stathis, Marcel Nijland, Avyakta Kallam, Jörg Bittenbring, Guillaume Cartron, Noémie Lang, Marjolein Van Der Poel, Loic Ysebaert, Vladan Vucinic, Alejandro Martin Garcia-Sancho, Antonio Rueda Dominguez, Noelia Purroy, Berengere De Moucheron, Xiaosong Li, Carla Guarinos, Joseph Burnett, Alicia Benítez Rondán, Michael Pourdehnad, Jessica Voetsch, Diego Sobradillo, Jean-Marie Michot
Journal: Blood
Blood (2025) 146 (Supplement 1): 480.
https://doi.org/10.1182/blood-2025-480
Published: 2025
Journal Articles

Multicenter real-world outcomes in limited stage (LS) diffuse large B-cell lymphoma (DLBCL) treated with abbreviated immunochemotherapy

Free
Hua-Jay Cherng, Drew Gerber, Chijioke Nze, Shahzeem Bhayani, David Russler-Germain, Ahmed Alnughmush, Paul Hampel, Kelsey Kille, Danielle Wallace, David Qualls, Reid Merryman, Jaden Brooks, Allison Bock, Juan Ramirez, Yumeng Zhang, Julio Chavez, Katelynn Granger, Katherine Antel, Cassandra Duarte, Ajay Major, Sirui Ma, Michael Spinner, Alyssa Mackay, Bei Hu, Manoj Rai, Stephen Spurgeon, Benjamin Lee, Jean Doh, Elizabeth Brem, Nicole Altomare, Reem Karmali, Robert Ryan, Yun Kyoung Tiger, Jordan Carter, Daniel Landsburg, Swetha Thiruvengadam, Alan Skarbnik, Yun Choi, David Bond, Ravand Samaeekia, Helen Ma, Seda Tolu, Jennifer Amengual, Alex Herrera, Barbara Pro
Journal: Blood
Blood (2025) 146 (Supplement 1): 471.
https://doi.org/10.1182/blood-2025-471
Published: 2025
Journal Articles

Outcomes and prognostic factors in patients with follicular lymphoma treated with front-line bendamustine and rituximab

Free
Hari Raman, Robert Redd, Wendy Dixon, Pari Ahmadi, Inhye Ahn, Amy Bessnow, Jennifer Brown, Jennifer Crombie, Matthew S Davids, David Fisher, Cynthia Hahn, Eric Jacobsen, Caron Jacobson, Austin Kim, Ann LaCasce, Oreofe Odejide, Erin Parry, David Qualls, Christine Ryan, Aswin Sekar, Mark Murakami, Philippe Armand, Reid Merryman
Journal: Blood
Blood (2025) 146 (Supplement 1): 1812.
https://doi.org/10.1182/blood-2025-1812
Published: 2025
Journal Articles

Rituximab and epcoritamab as first-line therapy for patients with high-tumor burden follicular lymphoma: Results of a multicenter phase II trial

Free
Reid Merryman, Danielle Wallace, Robert Redd, Heather Walker, Rafaella Tringale, Vanessa Kats, Siri Sagedahl, Ioulia Vogiatzi, Mingzeng Zhang, Emily Sumpena, Weihsin Chuan, Audrey Sigmund, Inhye Ahn, Amy Bessnow, Jennifer R. Brown, Jennifer Crombie, Matthew S Davids, David Fisher, Cynthia Hahn, Eric Jacobsen, Caron Jacobson, Austin Kim, Ann LaCasce, Oreofe Odejide, Erin Parry, David Qualls, Christine Ryan, Aswin Sekar, Sumana Devata, Carla Casulo, Kami Maddocks, Mark Murakami, Philippe Armand, Yazeed Sawalha
Journal: Blood
Blood (2025) 146 (Supplement 1): 464.
https://doi.org/10.1182/blood-2025-464
Published: 2025
Journal Articles

Sequencing CD20-directed bispecific antibody and CD19-directed CAR T cell therapy in large B cell lymphoma: A multicenter real-world study

Free
David Qualls, Andrew Jallouk, Geoffrey Shouse, Swetha Thiruvengadam, Omnia Farahat, Amy Ayers, Ayushi Chauhan, Reid Merryman, Ajay Major, Yazeed Sawalha, Narendranath Epperla, Matthew Lunning, Shakthi Bhaskar, Allison Bock, Steven Bair, Gilles Salles, Christopher Flowers, Alex Herrera, Lorenzo Falchi, Jennifer Crombie, Lei Feng, Sairah Ahmed
Journal: Blood
Blood (2025) 146 (Supplement 1): 3663.
https://doi.org/10.1182/blood-2025-3663
Published: 2025
Journal Articles

The current landscape of frontline large B-cell lymphoma trials

Available to Purchase
Clinical Trials & Observations
David Qualls, Philippe Armand, Gilles Salles
Journal: Blood
Blood (2025) 145 (2): 176–189.
https://doi.org/10.1182/blood.2023023789
Published: 2025
Journal Articles

A road map for navigating CAR T hematotoxicity

Free
David Qualls, Caron Jacobson
Journal: Blood
Blood (2023) 142 (10): 859–861.
https://doi.org/10.1182/blood.2023021305
Published: 2023
Journal Articles

Tafasitamab and Lenalidomide in Relapsed/Refractory Large B Cell Lymphoma (R/R LBCL): Real World Outcomes in a Multicenter Retrospective Study

Free
David Qualls, Michael J Buege, Phuong Dao, Paolo F. Caimi, Sarah C. Rutherford, Graham Wehmeyer, Jason T. Romancik, Lori A. Leslie, Mwanasha H. Merrill, Jennifer L. Crombie, Behzad Amoozgar, Brad S. Kahl, David A. Bond, Kami J. Maddocks, Michelle Okwali, Venkatraman Seshan, Gilles Salles, Connie Lee Batlevi
Journal: Blood
Blood (2022) 140 (Supplement 1): 787–789.
https://doi.org/10.1182/blood-2022-167620
Published: 2022
Journal Articles

Characterization of a Large Cohort of Patients with Nodal Marginal Zone Lymphoma Shows Prolonged Survival, Time-to-Treatment, and Time-to-Transformation

Free
Robert Stuver, Esther Drill, David Qualls, Michelle Okwali, Connie Lee Batlevi, Philip C Caron, Zachary D. Epstein-Peterson, Lorenzo Falchi, Audrey Hamilton, Paul A. Hamlin, Steven M. Horwitz, Andrew M. Intlekofer, William T. Johnson, Niloufer Khan, Oscar B Lahoud, Jennifer Kimberly Lue, Matthew J. Matasar, Alison J. Moskowitz, Ariela Noy, M.Lia Palomba, Santosha Vardhana, Andrew D. Zelenetz, Gilles Salles, David J. Straus
Journal: Blood
Blood (2022) 140 (Supplement 1): 9380–9382.
https://doi.org/10.1182/blood-2022-156383
Published: 2022
Journal Articles

BCL6 Rearranged Indolent B-Cell Lymphomas Show Mutational Profile Similar to Marginal Zone Lymphomas

Free
Pallavi K Galera, David Qualls, Umut Aypar, Caroline Kostrzewa, Menglei Zhu, Jeeyeon Baik, Venkatraman Seshan, Gilles Salles, Ahmet Dogan
Journal: Blood
Blood (2022) 140 (Supplement 1): 6396–6398.
https://doi.org/10.1182/blood-2022-163849
Published: 2022
Journal Articles

Favorable Outcomes of Patients with Limited-Stage Ocular Adnexal DLBCL Treated in the Rituximab Era: Long-Term Follow-up of a Single Center Experience

Free
David Qualls, Connie Lee Batlevi, Philip C Caron, Audrey Hamilton, Paul A. Hamlin, Steven M. Horwitz, Erel Joffe, Niloufer Khan, Anita Kumar, Matthew J. Matasar, Alison J. Moskowitz, Ariela Noy, Colette Owens, M. Lia Palomba, David J. Straus, Gottfried von Keudell, Andrew D. Zelenetz, Michelle Okwali, Joachim Yahalom, Heiko Schöder, Ahmet Dogan, Gilles Salles, Lorenzo Falchi
Journal: Blood
Blood (2021) 138 (Supplement 1): 4578.
https://doi.org/10.1182/blood-2021-153171
Published: 2021